Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia
Article in Cell Communication and Signaling (July 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Cell Communication and Signaling (July 2024)
Article in Journal of Medicinal Chemistry (June 2024)
Article in Archives of Pharmacal Research (June 2024)